Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
21%
OVERLAP
BY WEIGHT
17
# OF OVERLAPPING
HOLDINGS
WDNA
85
HOLDINGS
22%
ALSO IN CANC
CANC
56
HOLDINGS
30%
ALSO IN WDNA
SECTOR DRIFT (WDNA minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WDNA |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 3.1% | 4.6% | 3.1% |
|
JOHNSON & JOHNSON | 2.7% | 2.6% | 2.6% |
|
AMGEN INC | 2.2% | 2.7% | 2.2% |
|
IMMUNOME, INC. | 1.9% | 2.3% | 1.9% |
 |
NOVARTIS AG | 1.5% | 4.6% | 1.5% |
WDNA Overweight Relative to CANC
|
NATERA INC | 2.9% |
|
MODERNA, INC. | 2.6% |
|
STOKE THERAPEUTICS, INC. | 2.5% |
|
PFIZER INC | 2.4% |
|
UNITED THERAPEUTICS CORP | 2.3% |
|
REGENXBIO, INC. | 2.3% |
 |
BIONTECH SE SPONSORED ADR | 2.3% |
|
IONIS PHARMACEUTICALS, INC. | 2.2% |
|
AMICUS THERAPEUTICS INC | 2.2% |
 |
NOVO NORDISK A/S-B | 2.2% |
WDNA Underweight Relative to CANC
|
REVOLUTION MEDICINES, INC. | -7.2% |
 |
ASTRAZENECA PLC | -4.3% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -4.0% |
|
BRIDGEBIO PHARMA, INC. | -3.7% |
|
MERCK & CO. INC. | -3.2% |
|
NUVALENT, INC. CLASS A | -3.2% |
|
COGENT BIOSCIENCES INC | -3.1% |
|
NOVARTIS AG | -3.1% |
|
GENMAB A/S SPONSORED ADR | -2.5% |
|
CELCUITY INC. | -2.5% |